Testing early signs of dementia in patients with smell disorders
Official title: Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
Run by Danish Dementia Research Centre · NCT05740683 · Data updated 2026-11-12
This study is trying to see if people with smell problems show early signs of dementia with Lewy bodies, using a new test to help catch it sooner.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 55 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Danish Dementia Research Centre Research network |
| Locations | 2 sites (Copenhagen and 1 other locations) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | December 2032 |
| Study ends | December 2032 |
| Registry record updated | October 2, 2024 |
| Trial ID | NCT05740683 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 55-75 with slowly progressing idiopathic olfactory dysfunction.
✕Probably not a fit
Patients with diagnosed neurodegenerative diseases or those whose olfactory dysfunction is due to other medical conditions will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the relationship between idiopathic olfactory dysfunction and early warning signs of dementia with Lewy bodies (DLB). It utilizes a novel technique called Real-Time Quaking-Induced Conversion (RT-QuIC) to measure misfolded alpha-synuclein in patients with olfactory dysfunction compared to healthy controls. The study seeks to identify biomarkers and prodromal symptoms that could facilitate earlier diagnosis and intervention for DLB. By understanding these early signs, the research hopes to improve patient care and support the development of disease-modifying therapies.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and treatment options for patients at risk of developing dementia.
How similar studies have gone: While the approach of using RT-QuIC is novel, similar studies have shown promise in identifying early biomarkers for neurodegenerative diseases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria with patients iOD: * Age 55 -75 years of age * Slowly progressing and non-fluctuating iOD * Able to give informed consent and to cooperate as evaluated by the PI Exclusion criteria with patients iOD: * Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition. * Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function. * Olfactory dysfunction with response to systemic or local corticosteroids if tried * Severe nasal cavity abnormalities or infections. * Overt signs of dementia or PD * Current alcohol or drug abuse * Terminal illness * Diagnosed with neurodegenerative disease or major neurological/psychiatric condition. Inclusion criteria controls: * Age 55 -75 years of age * Able to give informed consent * Able to cooperate as evaluated by the PI Exclusion criteria controls: * Olfactory dysfunction on clinical test * Overt signs of dementia or PD * Severe nasal cavity abnormalities or infections. * Current alcohol or drug abuse * Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Where it's running
-
Danish Dementia Research Centre
Copenhagen, Denmark Recruiting -
Oskar McWilliam
Copenhagen, Denmark Recruiting
Study contacts
- Principal investigator: Kristian S Frederiksen — Danish Dementia Research Centre, Rigshospitalet, Capital Region
- Study coordinator: Oskar McWilliam
- Email: oskar.mcwilliam@regionh.dk
- Phone: +4535458759
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if smelling tests and guidance improve well-being for people with smell loss
This study tests whether giving people with smell dysfunction tailored information and guidance after smell testing can improve their mental health and use of care.
-
Topical PRP vs PRP injection for smell disorders
This study tests whether topical PRP applied with a carrier or PRP delivered by injection into the nasal area can improve smell in adults with long-standing olfactory dysfunction.
-
Investigating the effects of endoscopic skull base surgery on smell
This study tests how endoscopic skull base surgery affects the sense of smell in patients to better understand any smell-related problems that might happen after the surgery.
-
Evaluating a new olfactory training device for post-viral smell loss
This study is testing a new smell training device to see if it helps people who have lost their sense of smell after a virus recover better than a standard device.
-
Using a new device to improve sense of smell in older adults
This study is testing a new device to see if it can help older adults improve their sense of smell and overall well-being.
-
Slow-SPEED UK: A Double-Blind Feasibility Trial for a Digitally Supported Activity Program in Adults 40+ with Smell Loss
We’re testing whether a smartphone-enabled, wearable-guided activity plan can be safely and practically used by adults 40 and over who have a reduced sense of smell and low activity, to see if people can stick with it and accept it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.